company background image
8I8 logo

Integrated Diagnostics Holdings DB:8I8 Stock Report

Last Price

€0.32

Market Cap

€215.9m

7D

-4.7%

1Y

-19.4%

Updated

25 Mar, 2024

Data

Company Financials +

Integrated Diagnostics Holdings plc

DB:8I8 Stock Report

Market Cap: €215.9m

8I8 Stock Overview

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients.

8I8 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth6/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Integrated Diagnostics Holdings plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Integrated Diagnostics Holdings
Historical stock prices
Current Share PriceUS$0.32
52 Week HighUS$0.51
52 Week LowUS$0.23
Beta0.49
1 Month Change30.65%
3 Month Change10.96%
1 Year Change-19.40%
3 Year Change-61.52%
5 Year Changen/a
Change since IPO-63.64%

Recent News & Updates

Recent updates

Shareholder Returns

8I8DE HealthcareDE Market
7D-4.7%-1.8%1.6%
1Y-19.4%-2.3%6.4%

Return vs Industry: 8I8 underperformed the German Healthcare industry which returned -2% over the past year.

Return vs Market: 8I8 underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is 8I8's price volatile compared to industry and market?
8I8 volatility
8I8 Average Weekly Movement10.3%
Healthcare Industry Average Movement5.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8I8's share price has been volatile over the past 3 months.

Volatility Over Time: 8I8's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
19796,718Hend El Sherbinihttps://www.idhcorp.com

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria.

Integrated Diagnostics Holdings plc Fundamentals Summary

How do Integrated Diagnostics Holdings's earnings and revenue compare to its market cap?
8I8 fundamental statistics
Market cap€215.89m
Earnings (TTM)€10.48m
Revenue (TTM)€75.10m

20.7x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8I8 income statement (TTM)
Revenueج.م3.86b
Cost of Revenueج.م2.44b
Gross Profitج.م1.42b
Other Expensesج.م879.70m
Earningsج.م538.46m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.90
Gross Margin36.75%
Net Profit Margin13.96%
Debt/Equity Ratio3.6%

How did 8I8 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.